Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Liver Neoplasms × pembrolizumab × Clear all

Phase

Phase 2 5 Phase 1/2 4 Phase 1 4 Phase NA 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Skin Neoplasms 3 Neoplasms 3 Lung Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Melanoma 2 Carcinoma, Hepatocellular 2 Turcot syndrome 1 Squamous Cell Carcinoma of Head and Neck 1 Recurrence 1 Prostatic Neoplasms 1 Ovarian Neoplasms 1 Non-small Cell Lung Cancer Metastatic 1 Neoadjuvant Therapy 1 Mouth Neoplasms 1 Malignant Ascites 1 Liver Neoplasms 1 Glioma 1 Endometrial Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Small Cell 1 Carcinoma, Endometrioid 1

Interventions

Radiofrequency Ablation 5 lenvatinib 4 Radiosurgery 4 Electroporation 4 Radiotherapy 3 Hepatectomy 3 sintilimab 2 perflutren 2 Proton Therapy 2 Patient Navigation 2 Nutritional Status 2 Magnetic Resonance Spectroscopy 2 Liver Transplantation 2 Injections 2 Exercise 2 Dextrins 2 Cryosurgery 2 Control Groups 2 Anesthesia, General 2 toripalimab 1 tislelizumab 1 seocalcitol 1 pembrolizumab 1 motexafin gadolinium 1 gadofosveset trisodium 1 gadobutrol 1 gadobenic acid 1 erythromycin propionate-N-acetylcysteinate 1 durvalumab 1 camrelizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05339581 2022-04-27

iPLENTY-pvtt

RenJi Hospital

Phase NA Unknown

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡